Delivery Order SPE2DB20D3101-SPE2DB21FH1C2
- Not listed
- This federal contract award is for a Prime Vendor Pharmaceutical Distribution contract between the U.S. Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $17,504.19, is a Delivery Order placed under an Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies,...
- This federal contract award is from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order under DLA's Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, covers the supply of critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. This IDC serves as the...
- This federal contract award is for pharmaceutical and medical supply delivery services provided by Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical...
- This federal contract award is for a delivery order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through November 2026. The contract provides for the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract, which runs through November 2026, covers the supply of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes,...
- This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract covers the provision of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities,...
- This federal contract award is for pharmaceutical and medical supply services provided by Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, awarded by the Defense Logistics Agency (DLA), is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The IDC runs through November 2026 and covers a comprehensive range of pharmaceutical and medical commodities, including specialty medications, brand-name and generic...
- This federal contract award is for a prime vendor pharmaceutical supply contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00, and runs through December 2025. This Indefinite Delivery Contract (IDC) serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications,...
- This federal contract award is for a Prime Vendor Pharmaceutical contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,386.15, was awarded by the Defense Logistics Agency (DLA) and is for the delivery of a wide range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is a Delivery Order under an Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The contract covers the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits,...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB21FH1C2Delivery Order
This federal contract award is for a pharmaceutical prime vendor contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through November 2026. The contract covers the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract was awarded through full and open competition without any set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a separate IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 11/9/20 |